166 related articles for article (PubMed ID: 32468038)
1. Principal component analysis on LC‑MS/MS and 2DE‑MALDI‑TOF in glioblastoma cell lines reveals that mitochondria act as organelle sensors of the metabolic state in glioblastoma.
Gómez-Caudillo L; Ortega-Lozano AJ; Martínez-Batallar ÁG; Rosas-Vargas H; Minauro-Sanmiguel F; Encarnación-Guevara S
Oncol Rep; 2020 Aug; 44(2):661-673. PubMed ID: 32468038
[TBL] [Abstract][Full Text] [Related]
2. Interactions among mitochondrial proteins altered in glioblastoma.
Deighton RF; Le Bihan T; Martin SF; Gerth AMJ; McCulloch M; Edgar JM; Kerr LE; Whittle IR; McCulloch J
J Neurooncol; 2014 Jun; 118(2):247-256. PubMed ID: 24728830
[TBL] [Abstract][Full Text] [Related]
3. Search for a diagnostic/prognostic biomarker for the brain cancer glioblastoma multiforme by 2D-DIGE-MS technique.
Banerjee HN; Mahaffey K; Riddick E; Banerjee A; Bhowmik N; Patra M
Mol Cell Biochem; 2012 Aug; 367(1-2):59-63. PubMed ID: 22547198
[TBL] [Abstract][Full Text] [Related]
4. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of β-asarone induced cytotoxicity in human glioblastoma U251 cells.
Qi H; Chen L; Ning L; Ma H; Jiang Z; Fu Y; Li L
J Pharm Biomed Anal; 2015 Nov; 115():292-9. PubMed ID: 26263057
[TBL] [Abstract][Full Text] [Related]
6. Proteome Analysis of Hypoxic Glioblastoma Cells Reveals Sequential Metabolic Adaptation of One-Carbon Metabolic Pathways.
Zhang K; Xu P; Sowers JL; Machuca DF; Mirfattah B; Herring J; Tang H; Chen Y; Tian B; Brasier AR; Sowers LC
Mol Cell Proteomics; 2017 Nov; 16(11):1906-1921. PubMed ID: 28874504
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics of synaptic and nonsynaptic mitochondria: insights for synaptic mitochondrial vulnerability.
Stauch KL; Purnell PR; Fox HS
J Proteome Res; 2014 May; 13(5):2620-36. PubMed ID: 24708184
[TBL] [Abstract][Full Text] [Related]
8. Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy.
Rose M; Cardon T; Aboulouard S; Hajjaji N; Kobeissy F; Duhamel M; Fournier I; Salzet M
Front Immunol; 2021; 12():746168. PubMed ID: 34646273
[TBL] [Abstract][Full Text] [Related]
9. Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential.
Liu Z; Xu S; Li L; Zhong X; Chen C; Fan Y; Shen W; Zu L; Xue F; Wang M; Zhou Q
Thorac Cancer; 2019 May; 10(5):1111-1128. PubMed ID: 30950202
[TBL] [Abstract][Full Text] [Related]
10. iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.
Rajcevic U; Petersen K; Knol JC; Loos M; Bougnaud S; Klychnikov O; Li KW; Pham TV; Wang J; Miletic H; Peng Z; Bjerkvig R; Jimenez CR; Niclou SP
Mol Cell Proteomics; 2009 Nov; 8(11):2595-612. PubMed ID: 19674965
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer.
Lo YW; Lin ST; Chang SJ; Chan CH; Lyu KW; Chang JF; May EW; Lin DY; Chou HC; Chan HL
J Cell Mol Med; 2015 Apr; 19(4):744-59. PubMed ID: 25639359
[TBL] [Abstract][Full Text] [Related]
12. Rapid Proteomic Profiling by MALDI-TOF Mass Spectrometry for Better Brain Tumor Classification.
Petre G; Durand H; Pelletier L; Poulenard M; Nugue G; Ray PF; Rendu J; Coutton C; Berger F; Bidart M
Proteomics Clin Appl; 2020 Sep; 14(5):e1900116. PubMed ID: 32198817
[TBL] [Abstract][Full Text] [Related]
13. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
[TBL] [Abstract][Full Text] [Related]
14. The Goat (Capra hircus) Mammary Gland Mitochondrial Proteome: A Study on the Effect of Weight Loss Using Blue-Native PAGE and Two-Dimensional Gel Electrophoresis.
Cugno G; Parreira JR; Ferlizza E; Hernández-Castellano LE; Carneiro M; Renaut J; Castro N; Arguello A; Capote J; Campos AM; Almeida AM
PLoS One; 2016; 11(3):e0151599. PubMed ID: 27031334
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
16. [Effect of nordy on biological behaviors of malignant glioma cell line U87MG and the analysis of differential expression proteome].
Xu JP; Liu H; Bian XW; Chen JH; Zhou XD; Wu YZ
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):609-13. PubMed ID: 18070450
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.
Chen YW; Chou HC; Lyu PC; Yin HS; Huang FL; Chang WS; Fan CY; Tu IF; Lai TC; Lin ST; Lu YC; Wu CL; Huang SH; Chan HL
Funct Integr Genomics; 2011 Jun; 11(2):225-39. PubMed ID: 21246238
[TBL] [Abstract][Full Text] [Related]
18. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
Peng W; Zhang Y; Zhu R; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
[TBL] [Abstract][Full Text] [Related]
19. The proteomic response in glioblastoma in young patients.
Deighton RF; Le Bihan T; Martin SF; Barrios-Llerena ME; Gerth AM; Kerr LE; McCulloch J; Whittle IR
J Neurooncol; 2014 Aug; 119(1):79-89. PubMed ID: 24838487
[TBL] [Abstract][Full Text] [Related]
20. Multifarious proteomic signatures and regional heterogeneity in glioblastomas.
Park CK; Jung JH; Park SH; Jung HW; Cho BK
J Neurooncol; 2009 Aug; 94(1):31-9. PubMed ID: 19219580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
